What is the catalog number for CD18/ITGB2 Rabbit Polyclonal Antibody?

The catalog number for CD18/ITGB2 Rabbit Polyclonal Antibody is orb215895.

What sizes are available for CD18/ITGB2 Rabbit Polyclonal Antibody?

CD18/ITGB2 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is CD18/ITGB2 Rabbit Polyclonal Antibody in stock?

CD18/ITGB2 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

CD18/ITGB2 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Integrin beta-2; Cell surface adhesion glycoproteins LFA-1/CR3/p150, 95 subunit beta; Complement receptor C3 subunit beta; CD18; ITGB2; CD18, MFI7

UniProt

P05107

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human CD18 recombinant protein (Position: Q404-S769) . Human CD18 shares 76% amino acid (aa) sequence identity with mouse CD18.

Target

Integrin beta-2

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cell Biology, Disease Biomarkers, Immunology & Inflammation, Signal Transduction, Stem Cell & Developmental Biology

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human Immunohistochemistry (Paraffin-embedded Section), 2-5μg/ml, Human Immunofluorescence, 5μg/ml, Human

Form

Lyophilized

Molecular Weight

90-100 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IF, IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.